$9.36
-1.51-13.89%
Last update: Nov 5, 6:37 PM
Arcturus Therapeutics Holdings Inc
ARCTNASDAQ
The average analyst price target for Arcturus Therapeutics is $31.08, 212.7% above the current price. Of 11 analysts, 9 rate it Buy and 2 Hold. Targets range from $9 to $66. The latest change came on Oct 9, 2026, when Leerink Partners raised its price target on Arcturus Therapeutics from $13 to $19 and kept an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
